β-Catenin mutations are frequent in hepatocellular carcinomas but absent in adenomas induced by diethylnitrosamine in B6C3F1 mice

K Ogawa, Y Yamada, K Kishibe, K Ishizaki… - Cancer research, 1999 - AACR
K Ogawa, Y Yamada, K Kishibe, K Ishizaki, Y Tokusashi
Cancer research, 1999AACR
Activating mutations in the region of the β-catenin gene corresponding to the NH2-terminal
phosphorylation sites of glycogen synthetase kinase 3β have been causally implicated in
carcinogenesis. In this study, the β-catenin exon 3 was examined in hepatic lesions induced
by diethylnitrosamine in B6C3F1 mice. PCR and DNA sequencing detected seven β-catenin
mutations in 13 samples dissected from hepatocellular carcinoma tissues, but none in 14
hepatic adenomas. All of the mutations were found in codon 41 encoding a threonine …
Abstract
Activating mutations in the region of the β-catenin gene corresponding to the NH2-terminal phosphorylation sites of glycogen synthetase kinase 3β have been causally implicated in carcinogenesis. In this study, the β-catenin exon 3 was examined in hepatic lesions induced by diethylnitrosamine in B6C3F1 mice. PCR and DNA sequencing detected seven β-catenin mutations in 13 samples dissected from hepatocellular carcinoma tissues, but none in 14 hepatic adenomas. All of the mutations were found in codon 41 encoding a threonine residue, one of the possible glycogen synthetase kinase-3β phosphorylation sites. Although β-catenin protein was immunohistochemically stained mainly on the cell membrane in preneoplastic hepatocytic foci and most adenomas, as observed in normal hepatocytes, it was detected in the cytoplasm and nuclei in addition to the cell membrane, indicating stabilization of the protein in HCCs. This shift in staining was observed not only in tumors with mutations, but also in examples lacking exon 3 mutations. Our data demonstrate that β-catenin alterations may be important for malignant progression during multistep hepatic carcinogenesis in mice.
AACR